Related references
Note: Only part of the references are listed.Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel GSN Variant p.Glu580Lys
Maja Potrc et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The first Chinese renal gelsolin amyloidosis with the p.Asp174Asn mutation in the GSN gene: Nephrology picture
Rong Zhang et al.
JOURNAL OF NEPHROLOGY (2021)
A novel GSN variant outside the G2 calcium-binding domain associated with Amyloidosis of the Finnish type
Sean Mullany et al.
HUMAN MUTATION (2021)
The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers
Anna L. Bruckner et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis
Eeva-Kaisa Schmidt et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2019)
Gelsolin pathogenic Gly167Arg mutation promotes domain-swap dimerization of the protein
Francesco Boni et al.
HUMAN MOLECULAR GENETICS (2018)
Progressive cranial nerve involvement and grading of facial paralysis in gelsolin amyloidosis
Tiia Pihlamaa et al.
MUSCLE & NERVE (2016)
Natural course of Finnish gelsolin amyloidosis
Tuuli Nikoskinen et al.
ANNALS OF MEDICINE (2015)
Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred
Yvonne A. Efebera et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2014)
TGFBI, CHST6, and GSN gene analysis in Mexican patients with stromal corneal dystrophies
Johanna Gonzalez-Rodriguez et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Gelsolin: The Tail of a Molecular Gymnast
Shalini Nag et al.
CYTOSKELETON (2013)
A new Indian family affected by gelsolin amyloidosis
Boby Varkey Maramattom et al.
NEUROLOGY INDIA (2013)
Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy
Nelson Ferreira et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention
James P. Solomon et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis
Jennifer Ellis Ward et al.
BLOOD (2011)
Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy
Jouko Meretoja
CLINICAL GENETICS (2010)
Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis
Derliz Mereles et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens
Julie A. Vrana et al.
BLOOD (2009)
Familial systemic amyloidosis associated with bilateral sensorineural hearing loss and bilateral facial palsies
R. Hornigold et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2006)
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model
I. Cardoso et al.
FASEB JOURNAL (2006)
Neuromuscular pathology in hereditary gelsolin amyloidosis
S Kiuru-Enari et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Share Paper
